FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890425979> ?p ?o ?g. }

• W2890425979 endingPage "2494" @default.
• W2890425979 startingPage "2483" @default.
• W2890425979 abstract "Background and Purpose— Exosomes play a pivotal role in neurogenesis. In the peri-infarct area after stroke, axons begin to regenerate but are inhibited by astrocyte scar formation. The direct effect and underlying molecular mechanisms of astrocyte-derived exosomes on axonal outgrowth after ischemia are not known. Methods— Using a semaphorin 3A (Sema3A) inhibitor, we explored neuronal signaling during axonal outgrowth after ischemia in rats subjected to middle cerebral artery occlusion and in cultured cortical neurons challenged with oxygen-glucose deprivation. Furthermore, we assessed whether this inhibitor suppressed astrocyte activation and regulated astrocyte-derived exosomes to enhance axonal outgrowth after ischemia. Results— In rats subjected to middle cerebral artery occlusion, we administered a Sema3A inhibitor into the peri-infarct area from 7 to 21 days after occlusion. We found that phosphorylated high-molecular weight neurofilament-immunoreactive axons were increased, glial fibrillary acidic protein–immunoreactive astrocytes were decreased, and functional recovery was promoted at 28 days after middle cerebral artery occlusion. In cultured neurons, the Sema3A inhibitor decreased Rho family GTPase 1, increased R-Ras, which phosphorylates Akt and glycogen synthase kinase 3β (GSK-3β), selectively increased phosphorylated GSK-3β in axons, and thereby enhanced phosphorylated high-molecular weight neurofilament-immunoreactive axons after oxygen-glucose deprivation. In cultured astrocytes, the Sema3A inhibitor suppressed activation of astrocytes induced by oxygen-glucose deprivation. Exosomes secreted from ischemic astrocytes treated with the Sema3A inhibitor further promoted axonal elongation and increased prostaglandin D 2 synthase expression on microarray analysis. GSK-3β + and prostaglandin D 2 synthase + neurons were robustly increased after treatment with the Sema3A inhibitor in the peri-infarct area. Conclusions— Neuronal Rho family GTPase 1/R-Ras/Akt/GSK-3β signaling, axonal GSK-3β expression, and astrocyte-derived exosomes with prostaglandin D 2 synthase expression contribute to axonal outgrowth and functional recovery after stroke." @default.
• W2890425979 created "2018-09-27" @default.
• W2890425979 creator A5014705038 @default.
• W2890425979 creator A5016589120 @default.
• W2890425979 creator A5019184835 @default.
• W2890425979 creator A5029738963 @default.
• W2890425979 creator A5035479034 @default.
• W2890425979 creator A5036814115 @default.
• W2890425979 creator A5037688368 @default.
• W2890425979 creator A5041604185 @default.
• W2890425979 creator A5075749348 @default.
• W2890425979 date "2018-10-01" @default.
• W2890425979 modified "2023-10-16" @default.
• W2890425979 title "Astrocyte-Derived Exosomes Treated With a Semaphorin 3A Inhibitor Enhance Stroke Recovery via Prostaglandin D ₂ Synthase" @default.
• W2890425979 cites W1975370877 @default.
• W2890425979 cites W1975879045 @default.
• W2890425979 cites W1980251112 @default.
• W2890425979 cites W1987695717 @default.
• W2890425979 cites W1994215544 @default.
• W2890425979 cites W1995994458 @default.
• W2890425979 cites W2002412835 @default.
• W2890425979 cites W2004906982 @default.
• W2890425979 cites W2019211530 @default.
• W2890425979 cites W2033712349 @default.
• W2890425979 cites W2037510839 @default.
• W2890425979 cites W2058596914 @default.
• W2890425979 cites W2063120457 @default.
• W2890425979 cites W2064173164 @default.
• W2890425979 cites W2065817654 @default.
• W2890425979 cites W2067251312 @default.
• W2890425979 cites W2090389580 @default.
• W2890425979 cites W2104968232 @default.
• W2890425979 cites W2120209337 @default.
• W2890425979 cites W2143890525 @default.
• W2890425979 cites W2144117535 @default.
• W2890425979 cites W2155154752 @default.
• W2890425979 cites W2159233098 @default.
• W2890425979 cites W2178433510 @default.
• W2890425979 cites W2237126879 @default.
• W2890425979 cites W2297436559 @default.
• W2890425979 cites W2328577036 @default.
• W2890425979 cites W2498411827 @default.
• W2890425979 cites W2527897220 @default.
• W2890425979 cites W2561139731 @default.
• W2890425979 cites W2583401467 @default.
• W2890425979 cites W2612058584 @default.
• W2890425979 cites W2613058915 @default.
• W2890425979 cites W2738243416 @default.
• W2890425979 doi "https://doi.org/10.1161/strokeaha.118.021272" @default.
• W2890425979 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30355116" @default.
• W2890425979 hasPublicationYear "2018" @default.
• W2890425979 type Work @default.
• W2890425979 sameAs 2890425979 @default.
• W2890425979 citedByCount "68" @default.
• W2890425979 countsByYear W28904259792019 @default.
• W2890425979 countsByYear W28904259792020 @default.
• W2890425979 countsByYear W28904259792021 @default.
• W2890425979 countsByYear W28904259792022 @default.
• W2890425979 countsByYear W28904259792023 @default.
• W2890425979 crossrefType "journal-article" @default.
• W2890425979 hasAuthorship W2890425979A5014705038 @default.
• W2890425979 hasAuthorship W2890425979A5016589120 @default.
• W2890425979 hasAuthorship W2890425979A5019184835 @default.
• W2890425979 hasAuthorship W2890425979A5029738963 @default.
• W2890425979 hasAuthorship W2890425979A5035479034 @default.
• W2890425979 hasAuthorship W2890425979A5036814115 @default.
• W2890425979 hasAuthorship W2890425979A5037688368 @default.
• W2890425979 hasAuthorship W2890425979A5041604185 @default.
• W2890425979 hasAuthorship W2890425979A5075749348 @default.
• W2890425979 hasBestOaLocation W28904259791 @default.
• W2890425979 hasConcept C104629339 @default.
• W2890425979 hasConcept C11960822 @default.
• W2890425979 hasConcept C126322002 @default.
• W2890425979 hasConcept C134018914 @default.
• W2890425979 hasConcept C182996813 @default.
• W2890425979 hasConcept C184235292 @default.
• W2890425979 hasConcept C2777542381 @default.
• W2890425979 hasConcept C2778308172 @default.
• W2890425979 hasConcept C529278444 @default.
• W2890425979 hasConcept C71924100 @default.
• W2890425979 hasConcept C75217442 @default.
• W2890425979 hasConcept C86803240 @default.
• W2890425979 hasConcept C95444343 @default.
• W2890425979 hasConceptScore W2890425979C104629339 @default.
• W2890425979 hasConceptScore W2890425979C11960822 @default.
• W2890425979 hasConceptScore W2890425979C126322002 @default.
• W2890425979 hasConceptScore W2890425979C134018914 @default.
• W2890425979 hasConceptScore W2890425979C182996813 @default.
• W2890425979 hasConceptScore W2890425979C184235292 @default.
• W2890425979 hasConceptScore W2890425979C2777542381 @default.
• W2890425979 hasConceptScore W2890425979C2778308172 @default.
• W2890425979 hasConceptScore W2890425979C529278444 @default.
• W2890425979 hasConceptScore W2890425979C71924100 @default.
• W2890425979 hasConceptScore W2890425979C75217442 @default.
• W2890425979 hasConceptScore W2890425979C86803240 @default.
• W2890425979 hasConceptScore W2890425979C95444343 @default.
• W2890425979 hasIssue "10" @default.
• W2890425979 hasLocation W28904259791 @default.

• next